Peter Sfakianos, MD
Orthopedic Surgery · Folsom, CANPI 1295791465
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $845 of the $1,345 with a category attached, or 62.8%. 17 manufacturers reported payments, led by Bone Support Inc. at 37.2% of the total. Reporting peaked in 2021 at $618 and has fallen 69.3% since, to $189 in 2024.
Across 35 payments — averaging $38.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bone Support Inc.$500
- Stryker$180
- Pacira Therapeutics, Inc.$172
- Zimmer Biomet$63
- Fidia Pharma USA Inc.$53
- Amgen$53
- plus $324 from 11 others
What the payments were for
- Consulting fees$50037%
- Food & beverage$84563%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bone Support Inc. | 1 | $500 |
| Stryker | 2 | $180 |
| Pacira Therapeutics, Inc. | 8 | $172 |
| Zimmer Biomet | 2 | $63 |
| Fidia Pharma USA Inc. | 2 | $53 |
| Amgen | 3 | $53 |
| Johnson & Johnson(2 entities) | 3 | $50 |
| IBSA Pharma Inc. | 3 | $49 |
| Orthofix Medical, Inc. | 2 | $49 |
| Acell, Inc. | 2 | $34 |
| Integra Lifesciences Corporation | 1 | $32 |
| Vertex | 1 | $27 |
| Smith+Nephew | 1 | $21 |
| Davol Inc. | 1 | $21 |
| Bioventus LLC | 1 | $14 |
| Medtronic | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CERAMENTBONE VOID FILLER$500
- INSPACE$148
How this compares
$1,345 in reported general payments places this provider in the 60th percentile of 130 orthopedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 17 | $382 |
| Hydromorphone Hcl | 16 | $235 |
| Meloxicam | 50 | $202 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $181 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Folsom
- Dana VerchFolsom$2K
- Marshall ChingOroville$17.8M
- Ran SchwarzkopfOrange$2M
- Brian ChingOroville$1.4M
- Peter KurzweilLong Beach$494K
- Scott Hackerla Mesa$434K
- Richard NussbaumSherman Oaks$238K
- William KimTorrance$164K
- Peter BordenTorrance$111K
- Raymond FolmarIrvine$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.